SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: W Shakespeare who wrote (1406)12/7/1999 10:02:00 AM
From: MGV  Read Replies (1) of 1754
 
In point of fact, the Nidek verdict is completely irrelevant to BOL's and LASE's legal standing versus VISX.

I disagree. The basis for the interim decision in the ITC involves an assessment of the validity of one of the two patents before the court and the intell. prop. relevance of the other. A third ground for the decision is not relevant outside of the ITC (that VISX failed to prove that the LVC industry is a "domestic industry."

Any time the validity or relevance of VISX's IP is at issue, it is relevant to the industry and all of VISX's competitors.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News